- This event has passed.
Help Us Celebrate Achieve TMS East’s Chelmsford Grand Opening.
December 4, 2018
Join Achieve TMS East December 4th to Celebrate the Grand Opening of Our Chelmsford Location.
Achieve TMS East, Massachusetts’ largest provider of deep TMS therapy for the treatment of Depression and OCD, is pleased to announce the opening of its newest center in Chelmsford, MA. Achieve TMS East will be celebrating the opening of its Chelmsford office with a Ribbon Cutting Ceremony and Open House on Tuesday, December 4th from 12:00 – 1:30 pm at 1 Meeting House Road, Unit 3, Chelmsford, MA. Distinguished guests participating in the ceremony will be Achieve TMS East Psychiatrist, Rebecca Knapp, Director of Operations for Achieve TMS East, Marjorie Pierce, Paul Cohen, Chelmsford Town Manager, Michael McCall, Chelmsford Assistant Town Manager and Lisa Marrone, Chelmsford Director of Business Development.
The Ribbon Cutting ceremony will begin promptly at 12:00 pm and guests will then have the opportunity to tour the facility, participate in an informative presentation with a Q&A, and witness a hands-on demo with the TMS machine. Complimentary lunch and refreshments will be provided throughout the afternoon, and all providers and the general public are encouraged to attend. Following the Grand Opening, Achieve TMS East will be hosting public open houses once a month in their Chelmsford office.
Achieve TMS East, with 11 locations, is the largest provider of Brainsway’s Deep Transcranial Magnetic Stimulation (dTMS) in Massachusetts. Deep TMS therapy is used for the treatment of Depression and OCD. Major Depression is one of the most common psychiatric disorders in the United States and affects over 15 million adults overall. OCD or Obsessive-Compulsive Disorder affects over 2 million adults each year and approximately 50% of patients are resistant to first line treatments. Deep TMS therapy is launching a new era in the treatment of Depression and OCD and offers hope to those that are suffering from these diseases.
Brainsway’s Deep TMS, a safe, non-invasive treatment, is based on patents filed by the National Institute of Health and has been FDA (Federal Drug Administration) approved for the treatment of depression since 2013 and OCD since 2018. Deep TMS treatment stimulates a brain regions involved in depression and OCD and brings significant improvement to patients. The brief outpatient treatments allow for little to no disruption in a patient’s daily activity. Immediately after treatment, patients are able to drive home and return to their daily routine, including work commitments.
Please visit achievetmseast.com or call 413-923-2980 for additional information. Appointments are currently being accepted and patients may request a free informational session to determine if Brainsway’s Deep TMS is right for them.